Shilpa Medicare informs about press release
Shilpa Medicare has informed that it enclosed a press release on licensing agreement between Shilpa Biologicals (SBPL), a material subsidiary of the company, and Steincares, to commercialize its biosimilar across Latin America. The above information is also available on the website of the Company www.vbshilpa.com.
The above information is a part of company’s filings submitted to BSE.
